Centricity Universal Viewer with Cross Enterprise Display This impacts product versions 6.0 SP1 and higher.
Published October 24, 2018 · Recall initiated: August 30, 2018
Summary
FDA records medical device Class II recall Z-0195-2019, published October 24, 2018 and initiated August 30, 2018. Recalling firm: GE Healthcare, LLC; Status: Terminated; Reported quantity: 1; Lot: SYSTEM ID: 315470CPUWPV UDI #: 8406821038 00DE #: 2090255-001. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Remote comparison studies displayed may be associated with the wrong patient, without a caution icon present.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- GE Healthcare, LLC
- Distributor
- NY
- Lot
- SYSTEM ID: 315470CPUWPV UDI #: 8406821038 00DE #: 2090255-001
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDACentricity PACS Software Version 7.0 SP0.0.4.7August 3, 2022
- FDASIGNA Premier magnetic resonance scanner, model 5748519.July 27, 2022
- FDAGE Centricity Universal Viewer Zero Footprint. To view, communicate, process, and display Medical images andJuly 13, 2022
- FDABack up batteries in Avance CS2 and Avance CS2 Pro anesthesia devices manufactured on or after April 1, 2019July 6, 2022
- FDAHydrOXYzine HYDROCHLORIDE SYRUP (HydrOXYzine Hydrochloride Oral Solution, USP), 10 mg per 5 mL, Rx only,October 31, 2018
- FDAAtellica Sample Handler Prime (SMN 11069001). The Atellica" Solution is a multi-component system for in vitroOctober 24, 2018
Questions about this recall
Was Centricity Universal Viewer with Cross Enterprise Display This impacts product versions 6.0 SP1 and higher. recalled?
Yes. FDA published recall Z-0195-2019 on October 24, 2018. Reported hazard: Remote comparison studies displayed may be associated with the wrong patient, without a caution icon present.
What should I do if I have this product?
Voluntary: Firm initiated · Letter